Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs. The research is published March 21 in Microbiology Spectrum, a journal of the American Society for Microbiology.

21 Mar 2022

Study explores prevalence and symptom trajectory of long COVID

A new study estimated long-term COVID-19, or, long COVID, and the trajectory of disease symptoms in a representative sample in the US.

21 Mar 2022

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country's objectives in its fight against the coronavirus.

21 Mar 2022

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

David Sarabia had already sold two startups by age 26 and was sitting on enough money to never have to work another day in his life.

21 Mar 2022

Biological timeline of COVID-19 immune recovery described in new research

In a recent study published on the bioRxiv* preprint server, a group of researchers from the University of California, San Francisco, looked at intra-patient immunological changes over time to see if there were any changes in immune responses associated with successful COVID-19 resolution.

21 Mar 2022

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

A team of scientists from Turkey has recently evaluated the diversity and composition of gut microbiota in children diagnosed with multisystem inflammatory syndrome (MIS-C) and acute coronavirus disease 2019 (COVID-19). They have observed significant alteration in the gut microbiota composition in children with MIS-C. These changes are associated with autoimmunity, metabolic dysfunction, and obesity.

21 Mar 2022

Study links the usage of oral polio vaccines with lower incidence of COVID-19

A study published in the journal PLOS ONE showed how countries using oral polio vaccine have a lower incidence of coronavirus disease (COVID-19) when compared to those using inactivated polio vaccine – suggesting that the oral vaccine may either prevent the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the individual level or slow down the transmission in the community.

21 Mar 2022

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Researchers provide insight on the potentially significant impact of aerosol pH on the transmission of SARS-CoV-2.

20 Mar 2022

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

19 Mar 2022

Understanding how coronavirus, RS virus and rhinovirus affect children

When Inger Heimdal started studying the coronavirus in children in 2014, not many people thought the topic sounded particularly exciting.

18 Mar 2022

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

As SARS-CoV-2 has continued to evolve and outsmart existing treatments, scientists have not let up looking for ever-more effective tools to keep people safe and successfully recover from COVID-19, and to prepare for future outbreaks.

18 Mar 2022

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Researchers assessed the role of hypoxia-inducible factors in SARS-CoV-2 infection, respiratory symptoms, and epithelial damage.

18 Mar 2022

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Researchers analyzed the innate and adaptive responses to the mRNA-based BNT162b2 COVID-19 vaccine in mice.

18 Mar 2022

Characteristics of super-spreaders of novel coronaviruses

Researchers conducted a systematic review to evaluate the characteristics of super-spreaders of three novel coronaviruses that caused SARS, MERS, and COVID-19.

18 Mar 2022

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Researchers conducted a retrospective analysis to evaluate the duration of the SARS-CoV-2 Omicron variant virus shedding

18 Mar 2022

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

Study explores prevalence and symptom trajectory of long COVID

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

Biological timeline of COVID-19 immune recovery described in new research

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

Study links the usage of oral polio vaccines with lower incidence of COVID-19

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Understanding how coronavirus, RS virus and rhinovirus affect children

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Characteristics of super-spreaders of novel coronaviruses

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Study shows small airways disease with the presence of air trapping is a long-lasting sequelae of SARS-CoV-2 infection

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Research demonstrates within-host seasonal immunity

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in